Mrv1909 12241913572D 15 15 0 0 0 0 999 V2000 0.3627 0.8350 0.0000 C 0 0 2 0 0 0 0 0 0 0 0 0 1.0718 1.2482 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 0.3627 0.0000 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0 -0.3545 -0.4274 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0 -0.3464 -1.2482 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -1.0719 -0.0199 0.0000 C 0 0 2 0 0 0 0 0 0 0 0 0 -1.7811 -0.4329 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -1.0719 0.8151 0.0000 C 0 0 2 0 0 0 0 0 0 0 0 0 -0.3544 1.2425 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -1.7892 1.2226 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.5065 0.7952 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 1.0801 -0.4075 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 1.7892 0.0055 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.7892 0.8405 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 2.5065 -0.4020 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1 2 1 6 0 0 0 3 1 1 0 0 0 0 9 1 1 0 0 0 0 3 12 1 6 0 0 0 4 3 1 0 0 0 0 4 5 1 1 0 0 0 6 4 1 0 0 0 0 6 7 1 6 0 0 0 8 6 1 0 0 0 0 9 8 1 0 0 0 0 8 10 1 1 0 0 0 11 10 1 0 0 0 0 13 12 1 0 0 0 0 14 13 2 0 0 0 0 15 13 1 0 0 0 0 M END > DB03740 > drugbank > CC(=O)N[C@H]1[C@@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O > InChI=1S/C8H15NO6/c1-3(11)9-5-7(13)6(12)4(2-10)15-8(5)14/h4-8,10,12-14H,2H2,1H3,(H,9,11)/t4-,5-,6-,7-,8+/m1/s1 > OVRNDRQMDRJTHS-PVFLNQBWSA-N > C8H15NO6 > 221.2078 > 221.089937217 > 6 > 30 > -2.706797344266723e-05 > 20.419175901114627 > 1 > 5 > 0 > 0 > N-[(2S,3R,4R,5S,6R)-2,4,5-trihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide > -3.220574411666667 > 0 > 0 > 1 > 0 > 12.811681816700895 > 11.604129514800414 > -1.5720778168170406 > 119.25 > 47.024699999999996 > 2 > 1 > [(2R,3S,5R)-5-(5-fluoro-2,4-dioxo-3H-pyrimidin-1-yl)-3-hydroxyoxolan-2-yl]methoxyphosphonic acid > 0 > DB03740 > EXPT02319 > experimental > N-acetyl-alpha-D-glucosamine > 2-(acetylamino)-2-deoxy-A-D-glucopyranose; 2-(acetylamino)-2-deoxy-α-D-glucopyranose; N-acetyl-α-D-glucosamine; α-D-GlcNAc; α-GlcNAc $$$$